Bioject develops, manufactures and markets jet injection systems for needle-free drug delivery.
Business Model:
Revenue: $1.5M
Employees: 11-50
Bioject was acquired by
Inovio Pharmaceuticals.
The acquisition happend on 2016-05-02.
Details of the transaction were not public
Address: 7180 SW Sandburg St Ste 100
City: Tigard
State: OR
Zip: 97223
Country: US
Bioject develops, manufactures and markets jet injection systems for needle-free drug delivery.
Contact Phone:
+15036928001
Contact Email:
Listed Exchange:
OTCBB
Ticker Symbol:
BJCT.PK
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2013 | Venture Round | $994.5k | 12/2009 | Venture Round | $1.2M | 12/2006 | Debt Financing | 1 | $500k |
Partners for Growth Partners for Growth |
10/2013 | Debt Financing | $680k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|